Compare Cytokinetics Inc (CYTK) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Tilray Brands Inc — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Tilray Brands Inc trades at $4.78 (market cap $649.42M). The key difference: Cytokinetics Inc is far larger — about 16.4× Tilray Brands Inc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| CYTK | TLRY | |
|---|---|---|
Market Cap | $10.63B | $649.42M |
Sector | Technology | Health |
52-Week High | $87.26 | $21.00 |
52-Week Low | $34.31 | $3.88 |
Enterprise Value | $10.74B | $816.55M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
